Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial

✍ Scribed by Alba, E; Albanell, J; de la Haba, J; Barnadas, A; Calvo, L; Sánchez-Rovira, P; Ramos, M; Rojo, F; Burgués, O; Carrasco, E; Caballero, R; Porras, I; Tibau, A; Cámara, M C; Lluch, A

• Book ID: 121485508
• Publisher: Nature Publishing Group
• Year: 2014
• Tongue: English
• Weight: 231 KB
• Volume: 110
• Category: Article
• ISSN: 0007-0920
• DOI: 10.1038/bjc.2013.831